Skip to main content

HTRF FcRn Binding kit, 500 Assay Points

The FcRn binding kit is designed to monitor the binding of the IgG Fc region to the human FcRn receptor.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Part Number: 64FCRNPET
Unit Size: 100 Assay Points
Part Number: 64FCRNPEG
Unit Size: 500 Assay Points
Part Number: 64FCRNPEH
Unit Size: 10,000 Assay Points
  • The neonatal Fc receptor is an Fc receptor found in the placenta. It displays the unique feature of facilitating IgG transport from the mother to the growing fetus. This receptor also has an important role in modulating IgG and albumin half-life in the bloodstream, influencing the pharmacokinetic parameters through an FcRn-mediated transcytosis process. The FcRn kit measures the binding between Fc-based molecules and the FcRn receptor.

  • Assay Points
    500
    Assay Technology
    HTRF
    Brand
    HTRF
    Quantity
    1
    Shipping Conditions
    Shipped in Dry Ice
    Therapeutic Area
    Inflammation
    Neuroscience
    Oncology & Inflammation
    Unit Size
    500 Assay Points
  • Assay principle

    The FcRn receptor biochemical binding assay is a competitive assay involving the extracellular ectodomain of FcRn that is biotinylated and bound to Terbium cryptate-labeled Streptavidin, and human IgG1 labelled with d2. The unlabeled antibody or Fc fused drug competes with the d2 labelled IgG1 for binding to the receptor, resulting in a decrease in FRET signal.

    fcrn-binding-kit

     

    Assay protocol

    The FcRn biochemical binding assay needs only 1 incubation step after reagent distribution. Terbium Cryptate pre-labelled FcRn ectodomain is dispensed, followed by the addition of the sample and IgG1 labelled with d2. After 2h of incubation at RT, the signal can be read.

    fcrn-binding-kit

     

  • FcRn binding kit species selectivity

    IgG1 isotypes from human and mouse were serially diluted with the diluent buffer provided in the kit, starting from 1mg/mL. Human and Mouse IgG1 were then tested in a competition mode. The chart demonstrates that the human IgG1 antibody efficiently displaces the d2 labelled IgG1 antibody in a dose dependent manner, whereas the FRET signal remains constant when the mouse IgG1 concentration increases. These data indicate that the FcRn binding kit is human IgG specific and not compatible with other IgG species.

    fcrn-binding-kit

     

    Inhibitory effect of Rituximab and Pembrolizumab antibodies

    The inhibitory effects of two FDA approved antibodies, anti-CD20 Rituximab and the anti-PD1 Pembrolizumab, were investigated with the FcRn binding kit. The anti-CD20 IgG1 Rituximab and the anti-PD1 IgG4 Pembrolizumab were serially diluted with the diluent buffer provided in the kit, starting from 1 mg/mL and tested in a competition dose response. The data presented in the graph show that both antibodies efficiently compete with the d2-labelled antibody in a dose-dependent manner, and display similar IC50. The results show that the kit is compatible with human IgG1 and IgG4 antibodies.

    fcrn-binding-kit

     

Resources

1-2 of 2 Resources
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Flyer
Reagent solutions for autoimmunity research.

Advance your autoimmune disease research and benefit from Revvity broad offering of reagent technologies